World Psoriasis Day: From Stigma to Skin Clearance with Dr. Jessica Asgarpour Podcast Por  arte de portada

World Psoriasis Day: From Stigma to Skin Clearance with Dr. Jessica Asgarpour

World Psoriasis Day: From Stigma to Skin Clearance with Dr. Jessica Asgarpour

Escúchala gratis

Ver detalles del espectáculo

Obtén 3 meses por US$0.99 al mes + $20 crédito Audible

🎙️ World Psoriasis Day Special

This special World Psoriasis Day episode of The Skin and Joints Podcast shines a light on the evolving psoriasis journey—from the first plaque to total skin clearance. Dermatologist Dr. Jessica Asgarpour, now back in her sunny hometown of Calgary, joins us for an honest, hopeful conversation about how far psoriasis care has come—and where it’s headed next.

From coal tar and cumbersome creams to once-every-12-week biologic injections, Dr. Asgarpour unpacks the “treatment ladder” and what really determines when to climb it. Together they explore:

Why World Psoriasis Day (Oct 29) matters for awareness, stigma reduction, and timely re-referral

How to recognize when a patient is undertreated and ready for escalation

The topical-to-systemic continuum—including steroid-free innovations, orals vs. biologics, and the occasional role for IV therapy

Real-world barriers in access and adherence—from referral deserts to needle phobia

Matching therapy to patient lifestyle, comorbidities, and comfort level (“the clinic playbook”)

Why dermatologists today can say, confidently, that there is hope for every patient

It’s part myth-busting, part motivation—a must-listen whether you’re a clinician optimizing care or a patient ready to revisit your treatment options.

🎯 Learning Objectives

After listening to this episode, participants will be able to:

  • Describe the modern therapeutic ladder for psoriasis, from topicals and orals to biologics and infusions.
  • Identify clinical and quality-of-life criteria that signal the need for treatment escalation.
  • Discuss common barriers leading to undertreatment and strategies to enhance patient access and adherence.
  • Compare classes of biologic agents (TNF-α, IL-17, IL-23, IL-12/23) and their practical considerations in real-world care.
  • Empower patients with evidence-based reassurance about safety, efficacy, and long-term outcomes of advanced therapies.

🩵 World Psoriasis Day is more than awareness—it’s a call to action for clear skin, renewed confidence, and collaborative care.
#WorldPsoriasisDay #SkinAndJointsPodcast #PsoriasisAwareness #Dermatology #Biologics #PatientJourney #ClearSkinAhead

Supported by SUN Pharma.

ABOUT Dr. Jessica Asgarpour Dermatologist, Calgary, AB

Board-certified in both Canada and the U.S., Dr. Asgarpour completed medical school at the Cumming School of Medicine and her Dermatology residency at the University of Alberta. She practices medical, surgical, and cosmetic dermatology with a special interest in hidradenitis suppurativa and deroofing surgeries, as well as acne, psoriasis, eczema, skin cancer, and women’s health. She is currently working at the Skin Health and Wellness Centre in Calgary. She is a lecturer at the University of Toronto, a courtesy clinical associate at Women’s College Hospital, and is an active investigator for ongoing clinical trials in inflammatory diseases. She is a board member on the Canadian Hidradenitis Suppurativa foundation.

📻www.skinandjoints.ca

✉️info@skinandjoints.ca

📻www.skinandjoints.ca

✉️info@skinandjoints.ca


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Todavía no hay opiniones